Page last updated: 2024-08-24

valsartan and FMR1-Related Primary Ovarian Insufficiency

valsartan has been researched along with FMR1-Related Primary Ovarian Insufficiency in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abo-Youssef, AM; Attya, ME; Hemeida, RAM; Khallaf, WAI; Sharata, EE	1

Other Studies

1 other study(ies) available for valsartan and FMR1-Related Primary Ovarian Insufficiency

Article	Year
LCZ696 (sacubitril/valsartan) mitigates cyclophosphamide-induced premature ovarian failure in rats; the role of TLR4/NF-κB/NLRP3/Caspase-1 signaling pathway. Life sciences, 2023, Aug-01, Volume: 326 Topics: Animals; Caspase 1; Cyclophosphamide; Estrogens; Female; Follicle Stimulating Hormone; Interleukin-18; Luteinizing Hormone; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Primary Ovarian Insufficiency; Rats; Signal Transduction; Superoxide Dismutase; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Valsartan	2023

Article

Year

LCZ696 (sacubitril/valsartan) mitigates cyclophosphamide-induced premature ovarian failure in rats; the role of TLR4/NF-κB/NLRP3/Caspase-1 signaling pathway.

Life sciences, 2023, Aug-01, Volume: 326

Topics: Animals; Caspase 1; Cyclophosphamide; Estrogens; Female; Follicle Stimulating Hormone; Interleukin-18; Luteinizing Hormone; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Primary Ovarian Insufficiency; Rats; Signal Transduction; Superoxide Dismutase; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Valsartan

2023